Company / Book Value per Share
Repligen Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$37.2K
FY2025
5-year range
$30.6K / $37.2K
FY2021-FY2025
Trend
+5.6%
vs FY2024
Sector context
#1 of 209
Health Care
What the data says
Among 209 Health Care companies, Repligen is in the top 0% for book value per share. Book Value per Share has increased for 7 consecutive years, from $13.538 in FY2018 to $37,236.417 in FY2025.
Based on SEC 10-K filings.
$37,236.417 in FY2025 with a 5-year CAGR of +5.6%. Ranks 1st among 209 companies in Health Care.
Improved from $34,851.89 to $37,236.417 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +3.8%
- 5-Year CAGR
- +5.6%
- 10-Year CAGR
- -
Sector benchmark
+17164.2% above sector average
Key checks
Key Insights
- Repligen's book value per share has grown for 7 consecutive years.
- 5-year CAGR of +5.6%, indicating consistent growth.
- In FY2025, book value per share increased 5.6% year-over-year.
- Ranks #1 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -18.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $37.2K | +5.6% |
| FY2024 | $35.3K | +1.2% |
| FY2023 | $34.9K | +4.8% |
| FY2022 | $33.3K | +8.8% |
| FY2021 | $30.6K | +7.7% |
| FY2020 | $28.4K | +131644.7% |
| FY2019 | $21.537 | +59.1% |
| FY2018 | $13.538 | -22.5% |
| FY2017 | $17.479 | +241.3% |
| FY2016 | $5.122 | +61.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026